Bal Pharma Limited - Company Profile

Q: Who are the current directors of Bal Pharma Limited?

The current directors of Bal Pharma Limited are Ravindrakumar Kothari, Himesh Virupakshaya, Shailesh Dheerajmal Siroya, Nicola Neeladri, Jatish Sheth, Daddanala Venkat Bharath Bhushan, Abdul Basith, Bheekamchand Mukesh.

It is a pharma public limited company based in Bangalore South, Karnataka, India, established in 1987.

1987 Bangalore South, Karnataka, India Active

Last Updated: January 09, 2026

Access Report

About Bal Pharma Limited

Bal Pharma Limited, a active public limited company, was established on 19 May 1987 in Bangalore South, Karnataka, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: L85110KA1987PLC008368. Registered under ROC Roc Bangalore. it is listed on BSE: 524824 and NSE: BALPHARMA. It has an authorized capital of ₹24.50 Cr and a paid-up capital of ₹15.92 Cr.

It upholds a compliant status. In 2024, it reported revenue of ₹341.89 Cr and a net worth of ₹105.58 Cr. Employing 715 professional, Its leadership includes Ravindrakumar Kothari (Additional Director), Himesh Virupakshaya (Whole-Time Director), Shailesh Dheerajmal Siroya (Managing Director). Past directors included Kuruppath Ajitkumar, Shrenik Dheerajmal Siroya, Amarnath Raghunath Hegde. It holds ₹234.84 Cr open charges and ₹198.12 Cr settled loans. Its latest AGM occurred on 25 September 2025, with the balance sheet filed on 31 March 2025. It is based at 21-22, Bommasandra, Industrial Area, Bangalore South, Karnataka, 560099.

Company Details

CIN/LLPIN
L85110KA1987PLC008368
Registration Number
008368
Incorporation Date
19 May 1987
Authorized Capital
₹24.50 Cr
Paid-Up Capital
₹15.92 Cr
ROC Code
Roc Bangalore
Listing Status
Listed (BSE: 524824, NSE: BALPHARMA)
Company Status
Active

Key Metrics

Authorised Capital ₹ 24.50 Cr as on 09-01-2026
Paid Up Capital ₹ 15.92 Cr as on 09-01-2026
Company Age 38 Year, 8 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 234.84 Cr as on 09-01-2026
Satisfied Charges ₹ 198.12 Cr as on 09-01-2026
Revenue Growth **** 12.00% (FY 2024)
Profit Growth **** 67.68% (FY 2024)
Ebitda **** 24.62% (FY 2024)
Net Worth 9.94% (FY 2024)
Total Assets **** 3.91% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Bal Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Bal Pharma Limited?

Current Directors

Name	Designation	Appointment Date	Status
Ravindrakumar Kothari	Additional Director	05 May 2025	Current
Himesh Virupakshaya	Whole-Time Director	28 Sep 2019	Current
Shailesh Dheerajmal Siroya	Managing Director	01 Aug 2004	Current
Nicola Neeladri	Director	23 May 2020	Current
Jatish Sheth	Director	28 Dec 2020	Current
Bheekamchand Mukesh	Additional Director	13 Nov 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Nominee Director	01 Jan 2014	Past
Pramod Abcsdd	Director	31 Oct 2017	Past
Pramod Abcsdd	Whole-Time Director	30 May 2007	Past
Pramod Abcsdd	Director Appointed In Casual Vacancy	10 Aug 2017	Past
Pramod Abcsdd	Director	03 Feb 2012	Past
Pramod Abcsdd	Company Secretary	09 Jul 2015	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bal Pharma.

Bal Pharma Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 12% increase. The company also saw a substantial improvement in profitability, with a 67.68% increase in profit. The company's net worth moved up by a moderate rise of 9.94%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

12.00%

*******

Revenue from Operations

*******

11.69%

*******

Total Assets

*******

3.91%

*******

Profit or Loss

*******

67.68%

*******

Net Worth

*******

9.94%

*******

EBITDA

*******

24.62%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bal Pharma?

In 2024, Bal Pharma had a promoter holding of 51.24% and a public holding of 48.76%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹2,348,392,892.00

Satisfied Charges

₹1,981,218,570.00

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 106.58 Cr
Others : 64.83 Cr
Canara Bank : 58.78 Cr
Sidbi : 4.29 Cr
Axis Bank Limited : 0.36 Cr

Latest Charge Details

Date	Lender	Amount	Status
20 Nov 2025	Others	₹4.40 Cr	Open
13 Nov 2025	Hdfc Bank Limited	₹5.00 Cr	Open
23 Oct 2025	Hdfc Bank Limited	₹2.49 M	Open
28 Aug 2025	Others	₹22.00 Cr	Open
22 Aug 2025	Others	₹3.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Bal Pharma?

Bal Pharma has a workforce of 715 employees as of Mar 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Bal Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bal Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bal Pharma

Recent Activity within the Organization

Charges

Progress on A charge with Others of Rs. 22.00 Cr registered on 28 Aug 2025 with Charge ID 101169142 was modified on 27 Nov 2025. was documented.
27 Nov 2025
Charges

The activity A charge with Others amounted to Rs. 4.40 Cr with Charge ID 101186985 was registered on 20 Nov 2025. was completed.
20 Nov 2025
Charges

Progress on A charge with Hdfc Bank Limited amounted to Rs. 5.00 Cr with Charge ID 101183756 was registered on 13 Nov 2025. was documented.
13 Nov 2025
Director Appointment

The activity Bheekamchand Mukesh was appointed as a Additional Director was appointed as a Additional Director on 13 Nov 2025 & has been associated with this company since 2 months 28 days . was completed.
13 Nov 2025
Charges

The activity A charge with Hdfc Bank Limited amounted to Rs. 0.25 Cr with Charge ID 101180259 was registered on 23 Oct 2025. was completed.
23 Oct 2025
Charges

The activity A charge registered on 08 Feb 2024 via Charge ID 100873015 with Others was fully satisfied on 26 Sep 2025. was completed.
26 Sep 2025

Explore recent activity and updates - View Recent Activity